Andréa Gosset

ORCID: 0000-0003-0743-2458
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hepatitis B Virus Studies
  • HIV/AIDS Research and Interventions
  • Hepatitis Viruses Studies and Epidemiology
  • HIV, Drug Use, Sexual Risk
  • HIV Research and Treatment
  • Blood donation and transfusion practices
  • Antifungal resistance and susceptibility
  • Vaccine Coverage and Hesitancy
  • Blood groups and transfusion
  • Hepatitis C virus research
  • Monoclonal and Polyclonal Antibodies Research
  • Data-Driven Disease Surveillance
  • Sex work and related issues
  • Biological Research and Disease Studies
  • Blood transfusion and management
  • HIV/AIDS Impact and Responses
  • Enzyme Production and Characterization
  • Herpesvirus Infections and Treatments
  • Biochemical and Structural Characterization

Institut de Recherche pour le Développement
2016-2024

Economic & Social Sciences, Health Systems & Medical Informatics
2016-2024

Aix-Marseille Université
2016-2024

Inserm
2016-2024

ARPE PACA
2016-2018

Prompt uptake of antiretroviral treatment (ART) is essential to ensure the success universal test and treat (UTT) strategies prevent HIV transmission in high-prevalence settings. We describe ART initiation rates associated factors within an ongoing UTT cluster-randomized trial rural South Africa. HIV-positive individuals were offered immediate intervention arm vs. national guidelines recommended (CD4≤350 cells/mm(3)) control arm. used data collected up July 2015 among ART-eligible linked...

10.1080/09540121.2016.1164808 article EN cc-by AIDS Care 2016-06-02

Abstract Objective Economic feasibility of eliminating mother‐to‐child transmission (MTCT) hepatitis B virus (HBV) in highly endemic African countries remains uncertain. Prevention MTCT (PMTCT) involves screening pregnant women for surface antigen (HBsAg), identifying those with high viral loads or e (HBeAg), and administering tenofovir prophylaxis to high‐risk women. We estimated the costs integrating PMTCT services into antenatal care Burkina Faso, based on four different strategies select...

10.1002/ijgo.15515 article EN cc-by-nc-nd International Journal of Gynecology & Obstetrics 2024-04-03

To study retention in care (RIC) trajectories and associated factors patients eligible for antiretroviral therapy (ART) a universal test-and-treat setting (TasP trial, South Africa, 2012-2016).A cluster-randomized trial whereby individuals identified HIV positive after home-based testing were invited to initiate ART immediately (intervention) or following national guidelines (control).Exiting was defined as ≥3 months late clinic appointment, transferring elsewhere, death. Group-based...

10.1097/qai.0000000000001938 article EN cc-by JAIDS Journal of Acquired Immune Deficiency Syndromes 2018-12-22

Our website uses cookies to enhance your experience. By continuing use our site, or clicking "Continue," you are agreeing Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications Network Open Cardiology Dermatology Health Forum Internal Medicine Neurology Oncology Ophthalmology Otolaryngology–Head & Neck Surgery Pediatrics Psychiatry Archives of (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning /...

10.1001/jama.1933.02740320059032 article EN JAMA 1933-08-12

To achieve global hepatitis elimination by 2030, it is critical to prevent the mother-to-child transmission (MTCT) of B virus (HBV). Since 2009, WHO has recommended administering vaccine all neonates within 24 h birth MTCT. However, many countries in sub-Saharan Africa only provide immunization at age 6, 10, and 14 weeks or 8, 12, 16 using a combined vaccine. accelerate introduction dose (HepB-BD) into Africa, establish what extent addition HepB-BD can further reduce HBV areas where...

10.3390/vaccines9060583 article EN cc-by Vaccines 2021-06-01

Some African countries are still reluctant to introduce the hepatitis B vaccine birth dose (HepB-BD) into their expanded program of immunization (EPI), partly because logistical, economic, and cost information constraints. To assist decision-makers in these countries, we assessed economic financial costs HepB-BD introduction Senegal 2016. We performed a micro-costing study representative sample Senegal’s EPI sites at all levels 2018. Information on activity-related inputs was collected using...

10.3390/vaccines9050521 article EN cc-by Vaccines 2021-05-18

HIV-incidence studies are used to identify at-risk populations for HIV-prevention trials and interventions, but loss follow-up (LTFU) can bias results if participants who remain differ from those drop out. We investigated the incidence of factors associated with LTFU among Zambian female sex workers (FSWs) in an cohort 2012 2017. Enrolled returned at month one, three quarterly thereafter. FSWs were considered they missed six consecutive months, or their last visit was months before study end...

10.2989/16085906.2020.1836005 article EN African Journal of AIDS Research 2020-10-01
Coming Soon ...